Kalaimani Elango
Overview
Explore the profile of Kalaimani Elango including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schreiber A, Elango K, Soussu C, Fakhra S, Asad S, Ahsan C
Case Rep Cardiol
. 2022 Apr;
2022:9943937.
PMID: 35402051
. Currently, the literature regarding the management of COVID-19 induced cardiomyopathy with reduced ejection fraction is limited. In this case report, we present the first documented case of COVID-19 induced...
2.
Elango K, Mudgal M, Murthi S, Yella P, Nagrecha S, Srinivasan V, et al.
Int J Environ Res Public Health
. 2022 Mar;
19(5).
PMID: 35270461
Introduction: Pneumocystis Pneumonia (PCP) is a common opportunistic infection among people living with the human immunodeficiency virus (HIV). This study’s objective was to assess temporal trends in PCP epidemiology among...
3.
Schreiber A, Elango K, Hong K, Ahsan C
Eur Heart J Case Rep
. 2021 Jun;
5(6):ytab217.
PMID: 34189399
Background: Heart transplant recipients represent a particularly vulnerable patient population to the novel coronavirus disease 2019 (COVID-19) due to chronic immunosuppression and high rates of comorbidities. Currently, data are limited...
4.
Gunasekaran K, Voruganti D, Rahi M, Elango K, Ramalingam S, Geeti A, et al.
Cannabis Cannabinoid Res
. 2021 May;
6(4):340-348.
PMID: 33998884
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality in the United States. Due to the ongoing legalization of cannabis, its acceptance, availability, and use in the...
5.
Elango K, Javaid A, Khetarpal B, Ramalingam S, Kolandaivel K, Gunasekaran K, et al.
Cells
. 2021 Apr;
10(4).
PMID: 33807457
Warfarin has been utilized for decades as an effective anticoagulant in patients with a history of strong risk factors for venous thromboembolism (VTE). Established adverse effects include bleeding, skin necrosis,...
6.
Gunasekaran K, Murthi S, Elango K, Rahi M, Thilagar B, Ramalingam S, et al.
J Clin Med
. 2021 Jan;
10(2).
PMID: 33440707
(1) Background: Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. Diabetes mellitus (DM) has been shown to have adverse inflammatory effects on lung anatomy...
7.
Gunasekaran K, Rajasurya V, Devasahayam J, Rahi M, Chandran A, Elango K, et al.
J Clin Med
. 2020 Sep;
9(9).
PMID: 32942757
Anticoagulation carries a tremendous therapeutic advantage in reducing morbidity and mortality with venous thromboembolism and atrial fibrillation. For over six decades, traditional anticoagulants like low molecular weight heparin and vitamin...
8.
Tirunagari D, Murthi S, Sadat B, Elango K
BMJ Case Rep
. 2018 Oct;
2018.
PMID: 30344160
No abstract available.
9.
Mosleh W, Elango K, Shah T, Chaudhari M, Gandhi S, Kattel S, et al.
Echocardiography
. 2018 Sep;
35(11):1721-1728.
PMID: 30220086
Background: Acute myocardial infarction (MI) leads to ventricular remodeling in response to oxygen demand. Such changes include left ventricular (LV) dilatation and increased myocardial wall stress. Prior studies showed that...
10.
Elango K, Murthi S, Devasahayam J, Gunasekaran K
BMJ Case Rep
. 2018 Apr;
2018.
PMID: 29643143
No abstract available.